Melatonin associated with acid inhibition as a strategy for chemoprevention in Barrett's esophagus. pilot study [Melatonina asociada a inhibicion acida como estrategia de quimioprevencion en esofago de Barrett. Estudio piloto].

Trial Profile

Melatonin associated with acid inhibition as a strategy for chemoprevention in Barrett's esophagus. pilot study [Melatonina asociada a inhibicion acida como estrategia de quimioprevencion en esofago de Barrett. Estudio piloto].

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Melatonin (Primary) ; Omeprazole
  • Indications Barrett's oesophagus; Oesophageal cancer
  • Focus Biomarker; Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ISRCTN: Current Controlled Trials.
    • 20 Apr 2012 New source identified and integrated (ISRCTN: Current Controlled Trials; 95230916).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top